Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Operating Leases (2016 - 2025)

Historic Operating Leases for American Healthcare REIT (AHR) over the last 10 years, with Q3 2025 value amounting to $141.3 million.

  • American Healthcare REIT's Operating Leases fell 1890.62% to $141.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $141.3 million, marking a year-over-year decrease of 1890.62%. This contributed to the annual value of $165.2 million for FY2024, which is 2672.39% down from last year.
  • American Healthcare REIT's Operating Leases amounted to $141.3 million in Q3 2025, which was down 1890.62% from $148.2 million recorded in Q2 2025.
  • In the past 5 years, American Healthcare REIT's Operating Leases registered a high of $273.1 million during Q4 2022, and its lowest value of $9.9 million during Q1 2021.
  • Moreover, its 5-year median value for Operating Leases was $165.2 million (2024), whereas its average is $164.4 million.
  • Its Operating Leases has fluctuated over the past 5 years, first skyrocketed by 249834.35% in 2022, then crashed by 3202.33% in 2024.
  • Quarter analysis of 5 years shows American Healthcare REIT's Operating Leases stood at $145.5 million in 2021, then surged by 87.7% to $273.1 million in 2022, then fell by 17.42% to $225.5 million in 2023, then decreased by 26.72% to $165.2 million in 2024, then decreased by 14.5% to $141.3 million in 2025.
  • Its Operating Leases was $141.3 million in Q3 2025, compared to $148.2 million in Q2 2025 and $153.6 million in Q1 2025.